Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$507.14NASDAQ Closing Price as of 3:59PM ET 5/12/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+5.95(1.19%)
Bid (Size)$496.00 (4)
Ask (Size)$507.89 (1)
Day Low / High$497.00 - 513.67
Volume967.8 K
 

View Biotechnology IndustryPeer Comparison as of 05/12/2021

 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $507.14
Change: +5.95 (1.19%)
Volume: 967.8 K
3:59PM ET 5/12/2021
 
 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $212.68
Change: -0.32 (0.15%)
Volume: 1.2 M
4:00PM ET 5/12/2021
 
 

Illumina Inc ( NASDAQ )

Price: $372.84
Change: -8.67 (2.27%)
Volume: 817.3 K
3:59PM ET 5/12/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Biogen Inc ( NASDAQ )

Price: $274.02
Change: -4.37 (1.57%)
Volume: 929.7 K
3:59PM ET 5/12/2021
 

Read more news Recent News

Regeneron, Sanofi Report 'Positive' Libtayo Data From Phase 3 Trial for Advanced Cervical Cancer
3:16PM ET 5/12/2021 MT Newswires

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) cancer immunotherapy Libtayo improved survival in patients with advanced cervical cancer, delivering...

--Morgan Stanley Adjusts Price Target on Regeneron Pharmaceuticals to $495 From $477, Maintains Equal-Weight Rating
11:56AM ET 5/07/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--SVB Leerink Adjusts Price Target on Regeneron Pharmaceuticals to $641 From $657, Maintains Outperform Rating
11:12AM ET 5/07/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Research Alert: CFRA Keeps Hold Opinion On Shares Of Regeneron Pharmaceuticals, Inc.
4:05PM ET 5/06/2021 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Phone+1.914.847.7000
Number of Employees7,400
Recent SEC Filing05/10/20214
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Senior VP-Quality Assurance & OperationsPatrice Gilooly
Chief Financial Officer & Executive VP-FinanceRobert E. Landry

Company Highlights

Price Open$497.00
Previous Close$501.19
52 Week Range$441.00 - 664.64
Market Capitalization$53.1 B
Shares Outstanding104.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/04/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$29.52
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin41.35%
Return on Equity33.19%

Analyst Ratings as of 05/06/2021

Buy
14
Overweight
1
Hold
10
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset